Fretibacterium: Exploring Its Pathogenic Potential in Oral Infectious Diseases

Abstract Oral infectious diseases, particularly inflammatory periodontal lesions, exert a substantial impact on healthcare systems and economies, as acknowledged by the World Health Organization. The prevailing consensus attributes the onset of oral infectious diseases to dysbiosis within the intricate oral microbiome. In this context, Fretibacterium —a strictly anaerobic genus whose representative species, Fretibacterium fastidiosum , was classified in 2013 as the third human oral species within the Synergistetes phylum—has garnered attention for its progressive enrichment in periodontitis and distinct abundance profiles in health versus disease. This review synthesizes current knowledge on Fretibacterium ’s role in periodontal disease, dental caries, endodontic infections, and peri‐implantitis, with emphasis on its virulence mechanisms. Then further explore its clinical associations with systemic conditions (e.g., diabetes) and evaluate conventional and emerging therapeutic strategies. By providing evidence‐based insights, this work aims to guide clinical management and future research directions.